Synopsis
0
VMF
0
Australia
DRUG PRODUCT COMPOSITIONS0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Anhydrous, Ciprofloxacin Hydrochloride
2. Bay 09867
3. Bay-09867
4. Bay09867
5. Ciprinol
6. Cipro
7. Ciprofloxacin
8. Ciprofloxacin Hydrochloride Anhydrous
9. Ciprofloxacin Monohydrochloride Monohydrate
10. Hydrochloride Anhydrous, Ciprofloxacin
11. Hydrochloride, Ciprofloxacin
12. Monohydrate, Ciprofloxacin Monohydrochloride
13. Monohydrochloride Monohydrate, Ciprofloxacin
1. Ciprofloxacin Hcl
2. 93107-08-5
3. 86483-48-9
4. 1-cyclopropyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic Acid Hydrochloride
5. Cipro
6. Chebi:310388
7. Ciprofloxacin Hydrochloride Anhydrous
8. 0mp32mfp6c
9. 1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylic Acid Hydrochloride
10. Ciprofloxacin (monohydrochloride)
11. Bay-o-9867
12. Ciprofloxacin Hydrochloride (anh.)
13. Bay O 9867
14. Cetraxal
15. Ciprobay
16. Ciproxan
17. Ciproxin
18. Flociprin
19. Ciflox
20. Mfcd00079044
21. 1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylic Acid Hcl
22. 1-cyclopropyl-6-fluoro-4-oxo-7-piperazin-1-ylquinoline-3-carboxylic Acid;hydrochloride
23. 1-cyclopropyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic Acid Xhydrochloride
24. Bay-o 9867
25. 93107-08-5 (hcl)
26. 1-cyclopropyl-6-fluoro-4-oxo-7-(1-piperazinyl)-1,4-dihydro-3-quinolinecarboxylic Acid Hydrochloride
27. Dsstox_cid_27768
28. Dsstox_rid_82545
29. Dsstox_gsid_47788
30. Ciprofloxacin (as Hydrochloride)
31. Prestwick_67
32. 1-cyclopropyl-6-fluoro-4-oxo-7-piperazin-1-yl-1,4-dihydro-quinoline-3-carboxylic Acid; Hydrochloride
33. 4-(3-carboxy-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-quinolin-7-yl)-piperazin-1-ium; Chloride
34. Cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylic Acid, Monohydrochloride
35. Nsc620634
36. Ciprofloxacin Hydrochloride (anhydrous)
37. Ciprofloxacin 100 Microg/ml In Methanol
38. Ncgc00016959-01
39. Cas-93107-08-5
40. Unii-0mp32mfp6c
41. 3-quinolinecarboxylic Acid, 1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-, Hydrochloride
42. 3-quiolinecarboxylic Acid
43. Ciprofloxacine Hydrochloride
44. Epitope Id:174846
45. Cambridge Id 5807784
46. Ciprofloxacini Hydrochloridum
47. Chembl1202
48. Schembl42310
49. 1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylic Acid Monohydrochloride
50. 3-quinolinecarboxylic Acid, 1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-, Monohydrochloride
51. Ciprofloxacin Hcl/lactate
52. Dtxsid1047788
53. Hy-b0356a
54. Ciprofloxacin Hydrochloride (1:x)
55. Hms1568g08
56. Bcp13634
57. Bcp14336
58. Tox21_110712
59. S5008
60. Akos005111008
61. Tox21_110712_1
62. Cs-8134
63. Ks-5012
64. Nsc-620634
65. Sb73037
66. Ncgc00016959-06
67. 3-quinolinecarboxylic Acid, 1,4-dihydro-1-cyclopropyl-6-fluoro-4-oxo-7-(1-piperazinyl)-, Hydrochloride
68. Ac-23972
69. Bim-0048462.p001
70. Ciprofloxacin 1000 Microg/ml In Methanol
71. Ciprofloxacin Hydrochloride [who-dd]
72. Ft-0623850
73. Ft-0623851
74. A16969
75. H10663
76. A859872
77. Q-200860
78. Q27105154
79. F0001-2378
80. Cpx; Cetraxal; Ciloxan; Cipro; Bay-09867 Hydrochloride
81. 1-cyclopropyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic Acid Hcl
82. 1-cyclopropyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylicacidxhydrochloride
83. 3-quinolinecarboxylic Acid, 1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-, Hydrochloride (1:1)
| Molecular Weight | 367.8 g/mol |
|---|---|
| Molecular Formula | C17H19ClFN3O3 |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 7 |
| Rotatable Bond Count | 3 |
| Exact Mass | 367.1098973 g/mol |
| Monoisotopic Mass | 367.1098973 g/mol |
| Topological Polar Surface Area | 72.9 Ų |
| Heavy Atom Count | 25 |
| Formal Charge | 0 |
| Complexity | 571 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
| 1 of 2 | |
|---|---|
| Drug Name | Ciprofloxacin hydrochloride |
| PubMed Health | Ciprofloxacin Betaine/Ciprofloxacin Hydrochloride (By mouth) |
| Drug Classes | Antibacterial |
| Drug Label | Ciprofloxacin Tablets, USPis a synthetic broad spectrum antimicrobial agent for oral administration. Ciprofloxacin hydrochloride, USP, a fluoroquinolone, is the monohydrochloride monohydrate salt of 1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-pip... |
| Active Ingredient | Ciprofloxacin hydrochloride |
| Dosage Form | Solution/drops; Tablet |
| Route | Ophthalmic; Oral |
| Strength | eq 100mg base; eq 750mg base; eq 500mg base; eq 0.3% base; eq 250mg base |
| Market Status | Prescription |
| Company | Watson Labs; Nexus Pharms; Ranbaxy; Ivax Sub Teva Pharms; Apotex; Bausch And Lomb; Aurobindo Pharma; Taro; Dr Reddys Labs; Unique Pharm Labs; Carlsbad; Pharmaforce; Fdc; Mylan; Hikma; Akorn |
| 2 of 2 | |
|---|---|
| Drug Name | Ciprofloxacin hydrochloride |
| PubMed Health | Ciprofloxacin Betaine/Ciprofloxacin Hydrochloride (By mouth) |
| Drug Classes | Antibacterial |
| Drug Label | Ciprofloxacin Tablets, USPis a synthetic broad spectrum antimicrobial agent for oral administration. Ciprofloxacin hydrochloride, USP, a fluoroquinolone, is the monohydrochloride monohydrate salt of 1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-pip... |
| Active Ingredient | Ciprofloxacin hydrochloride |
| Dosage Form | Solution/drops; Tablet |
| Route | Ophthalmic; Oral |
| Strength | eq 100mg base; eq 750mg base; eq 500mg base; eq 0.3% base; eq 250mg base |
| Market Status | Prescription |
| Company | Watson Labs; Nexus Pharms; Ranbaxy; Ivax Sub Teva Pharms; Apotex; Bausch And Lomb; Aurobindo Pharma; Taro; Dr Reddys Labs; Unique Pharm Labs; Carlsbad; Pharmaforce; Fdc; Mylan; Hikma; Akorn |
Treatment of chronic pulmonary infections caused by Pseudomonas aeruginosa
Anti-Bacterial Agents
Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)
Topoisomerase II Inhibitors
Compounds that inhibit the activity of DNA TOPOISOMERASE II. Included in this category are a variety of ANTINEOPLASTIC AGENTS which target the eukaryotic form of topoisomerase II and ANTIBACTERIAL AGENTS which target the prokaryotic form of topoisomerase II. (See all compounds classified as Topoisomerase II Inhibitors.)
Cytochrome P-450 CYP1A2 Inhibitors
Drugs and compounds which inhibit or antagonize the biosynthesis or actions of CYTOCHROME P-450 CYP1A2. (See all compounds classified as Cytochrome P-450 CYP1A2 Inhibitors.)
API SUPPLIERS
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.
Temad- We think of world-class quality.
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
NDC Package Code : 55111-010
Start Marketing Date : 1998-11-24
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Emay Pharmaceuticals is a GMP-certified API manufacturing company.
Jai Radhe Sales is your partner for all your sourcing needs.
Faran Shimi: Leading producer of high-quality APIs & alkaloid opiates, serving major pharmaceutical companies across the Middle East.
HRV Global Life Sciences - Market Expansion Leader in Pharmaceuticals.
Neuland Laboratories- A dedicated 100% API provider.
GDUFA
DMF Review : Reviewed
Rev. Date : 2012-10-26
Pay. Date : 2012-12-13
DMF Number : 13250
Submission : 1998-09-29
Status : Active
Type : II
Certificate Number : CEP 2000-405 - Rev 13
Issue Date : 2024-10-16
Type : Chemical
Substance Number : 888
Status : Valid
Date of Issue : 2022-06-08
Valid Till : 2025-06-16
Written Confirmation Number : WC-0037
Address of the Firm :
NDC Package Code : 58032-0006
Start Marketing Date : 2017-12-14
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Registrant Name : Sungwoo Chemical Co., Ltd.
Registration Date : 2019-01-31
Registration Number : 20080507-85-D-53-09(1)
Manufacturer Name : Neuland Laboratories Ltd
Manufacturer Address : Plot No.s 92,93,94,257,258,259 IDA, Pashamylaram, Isnapur, Patancheru(M), Medak Dist. -502 319, Andhra Pradesh, India
Tenatra connects Indian manufacturers with global buyers through active partners in Germany, Switzerland, Belgium, Spain & Turkey.
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
Neuland Laboratories- A dedicated 100% API provider.
Neuland Laboratories- A dedicated 100% API provider.
Certificate Number : CEP 2000-405 - Rev 13
Status : Valid
Issue Date : 2024-10-16
Type : Chemical
Substance Number : 888
Certificate Number : R1-CEP 2005-106 - Rev 02
Status : Withdrawn by Holder
Issue Date : 2017-11-06
Type : Chemical
Substance Number : 888
Certificate Number : R1-CEP 2001-097 - Rev 03
Status : Withdrawn by Holder
Issue Date : 2014-07-28
Type : Chemical
Substance Number : 888
Certificate Number : R1-CEP 2006-045 - Rev 01
Status : Withdrawn by Holder
Issue Date : 2018-01-11
Type : Chemical
Substance Number : 888
Certificate Number : R0-CEP 2008-176 - Rev 01
Status : Withdrawn by Holder
Issue Date : 2011-09-07
Type : Chemical
Substance Number : 888
Certificate Number : R1-CEP 2005-045 - Rev 00
Status : Withdrawn by Holder
Issue Date : 2012-09-19
Type : Chemical
Substance Number : 888
Certificate Number : R0-CEP 2011-051 - Rev 00
Status : Withdrawn by EDQM Failure to CEP pro...
Issue Date : 2012-12-10
Type : Chemical
Substance Number : 888
Certificate Number : R0-CEP 2008-241 - Rev 00
Status : Expired
Issue Date : 2013-05-10
Type : Chemical
Substance Number : 888
Certificate Number : R1-CEP 2006-072 - Rev 05
Status : Withdrawn by Holder
Issue Date : 2019-06-03
Type : Chemical
Substance Number : 888
Certificate Number : R0-CEP 2005-215 - Rev 00
Status : Withdrawn by Holder
Issue Date : 2007-06-01
Type : Chemical
Substance Number : 888
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Canada
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]DRUG PRODUCT COMPOSITIONS
DOSAGE - SOLUTION/DROPS;OPHTHALMIC - EQ 0.3% ...DOSAGE - SOLUTION/DROPS;OPHTHALMIC - EQ 0.3% BASE
USFDA APPLICATION NUMBER - 19992
DOSAGE - OINTMENT;OPHTHALMIC - EQ 0.3% BASE
USFDA APPLICATION NUMBER - 20369
DOSAGE - SUSPENSION/DROPS;OTIC - EQ 0.2% BASE...DOSAGE - SUSPENSION/DROPS;OTIC - EQ 0.2% BASE;1%
USFDA APPLICATION NUMBER - 20805
Related Excipient Companies
EUROAPI
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Rochem International Inc
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]SPI Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Seqens
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Faran Shimi Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Boai NKY Pharmaceuticals Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Healthcare
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nanjing Well Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pfanstiehl
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]ACG Worldwide
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Actylis
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Aeon Procare
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Alcedo Pharmachem
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Anhui Sunhere Pharmaceutical Excipients Co.,Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Clariant
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Corel Pharma Chem
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Curia
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]DFE Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Finar
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Chemicals
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Ideal Cures Pvt Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Ingredion Pharma Solutions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Kerry
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Kima Chemical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Lonza Capsugel
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Microlex e.U
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nanjing Bold Chemical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nomisma Healthcare
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Novo Excipients
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pharmatrans-Sanaq
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pluviaendo
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Prachin Chemical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Qianhao Chemical (Hebei) Co., Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Qualicaps
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Roquette
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Seppic
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Shanghai Shenmei Pharmaceutical Technology Co., Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Shanghai Welltone Material Technology Co., Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Shijiazhuang Huaxu Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Sigachi Industries
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]The Dow Chemical Company
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Ulanqab Kema New Material
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Excipients by Applications
Fillers, Diluents & Binders
Coating Systems & Additives
Disintegrants & Superdisintegrants
Solubilizers
Direct Compression
Controlled & Modified Release
Granulation
Thickeners and Stabilizers
Parenteral
Topical
Taste Masking
Lubricants & Glidants
Film Formers & Plasticizers
Chewable & Orodispersible Aids
Co-Processed Excipients
Emulsifying Agents
API Stability Enhancers
Surfactant & Foaming Agents
Rheology Modifiers
Empty Capsules
Coloring Agents
Vegetarian Capsules
Digital Content
DATA COMPILATION #PharmaFlow
NEWS #PharmaBuzz
Global Sales Information
US Medicaid Prescriptions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
Patents & EXCLUSIVITIES
US Patents
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
65
PharmaCompass offers a list of Ciprofloxacin Hydrochloride API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Ciprofloxacin Hydrochloride manufacturer or Ciprofloxacin Hydrochloride supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Ciprofloxacin Hydrochloride manufacturer or Ciprofloxacin Hydrochloride supplier.
PharmaCompass also assists you with knowing the Ciprofloxacin Hydrochloride API Price utilized in the formulation of products. Ciprofloxacin Hydrochloride API Price is not always fixed or binding as the Ciprofloxacin Hydrochloride Price is obtained through a variety of data sources. The Ciprofloxacin Hydrochloride Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Cipro manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Cipro, including repackagers and relabelers. The FDA regulates Cipro manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Cipro API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Cipro manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Cipro supplier is an individual or a company that provides Cipro active pharmaceutical ingredient (API) or Cipro finished formulations upon request. The Cipro suppliers may include Cipro API manufacturers, exporters, distributors and traders.
click here to find a list of Cipro suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Cipro DMF (Drug Master File) is a document detailing the whole manufacturing process of Cipro active pharmaceutical ingredient (API) in detail. Different forms of Cipro DMFs exist exist since differing nations have different regulations, such as Cipro USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Cipro DMF submitted to regulatory agencies in the US is known as a USDMF. Cipro USDMF includes data on Cipro's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Cipro USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Cipro suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Cipro Drug Master File in Japan (Cipro JDMF) empowers Cipro API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Cipro JDMF during the approval evaluation for pharmaceutical products. At the time of Cipro JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Cipro suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Cipro Drug Master File in Korea (Cipro KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Cipro. The MFDS reviews the Cipro KDMF as part of the drug registration process and uses the information provided in the Cipro KDMF to evaluate the safety and efficacy of the drug.
After submitting a Cipro KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Cipro API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Cipro suppliers with KDMF on PharmaCompass.
A Cipro CEP of the European Pharmacopoeia monograph is often referred to as a Cipro Certificate of Suitability (COS). The purpose of a Cipro CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Cipro EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Cipro to their clients by showing that a Cipro CEP has been issued for it. The manufacturer submits a Cipro CEP (COS) as part of the market authorization procedure, and it takes on the role of a Cipro CEP holder for the record. Additionally, the data presented in the Cipro CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Cipro DMF.
A Cipro CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Cipro CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Cipro suppliers with CEP (COS) on PharmaCompass.
A Cipro written confirmation (Cipro WC) is an official document issued by a regulatory agency to a Cipro manufacturer, verifying that the manufacturing facility of a Cipro active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Cipro APIs or Cipro finished pharmaceutical products to another nation, regulatory agencies frequently require a Cipro WC (written confirmation) as part of the regulatory process.
click here to find a list of Cipro suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Cipro as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Cipro API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Cipro as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Cipro and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Cipro NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Cipro suppliers with NDC on PharmaCompass.
Cipro Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Cipro GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Cipro GMP manufacturer or Cipro GMP API supplier for your needs.
A Cipro CoA (Certificate of Analysis) is a formal document that attests to Cipro's compliance with Cipro specifications and serves as a tool for batch-level quality control.
Cipro CoA mostly includes findings from lab analyses of a specific batch. For each Cipro CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Cipro may be tested according to a variety of international standards, such as European Pharmacopoeia (Cipro EP), Cipro JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Cipro USP).
